Healthcare & Life Sciences Insights
Discover Latham’s latest insights into the commercial, regulatory, and legal developments shaping the global healthcare and life sciences landscape.
Latham’s cross-disciplinary team delivers insightful, practical guidance and sophisticated representation to a full spectrum of healthcare and life sciences companies across the globe, on every type of transaction or dispute a company may face.
Trending Topics
Featured Insights
Our Work
Latham & Watkins Advises Chugai Pharmaceutical in US$1.085 Billion License Agreement With Rani Therapeutics
Latham & Watkins Advises Owlet on US$30 Million Class A Stock Offering After Advising on Exchange of Series A and Series B Warrants
Recognition
Distinguished Leader: David Tolley
Chair of Latham & Watkins' Boston Litigation & Trial Department honored as a winner by the New England Legal Awards.
Litigators of the Week Winner: Truce With Generic Makers Over Rinvoq Sends AbbVie Share Price to New High
A Latham team led by David Frazier won the “Litigators of the Week” competition, alongside co-counsel at Covington, for their outstanding representation of AbbVie in securing the latest of five patent litigation settlements with generic makers that are set to protect its blockbuster immunology drug Rinvoq until 2037.
Mark Bekheit Named Among Top 100 Lawyers in California
Bay Area offices managing partner was honored for his leadership and M&A practice work.